Gerresheimer GRRMF Stock
Gerresheimer Price Chart
Gerresheimer GRRMF Financial and Trading Overview
| Gerresheimer stock price | 29.05 USD |
| Previous Close | 29.05 USD |
| Open | 32.2 USD |
| Bid | 29.8 USD x 30000 |
| Ask | 32.33 USD x 10000 |
| Day's Range | 32.2 - 32.2 USD |
| 52 Week Range | 19.17 - 51.41 USD |
| Volume | 200 USD |
| Avg. Volume | 32 USD |
| Market Cap | 1B USD |
| Beta (5Y Monthly) | 0.448 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.36 USD |
| Forward Dividend & Yield | 0.05 (0%) |
| Ex-Dividend Date | June 6, 2025 |
| 1y Target Est | N/A |
GRRMF Valuation Measures
| Enterprise Value | 3.19B USD |
| Trailing P/E | N/A |
| Forward P/E | 5.069808 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.43302074 |
| Price/Book (mrq) | 0.93198246 |
| Enterprise Value/Revenue | 1.375 |
| Enterprise Value/EBITDA | 9.861 |
Trading Information
Gerresheimer Stock Price History
| Beta (5Y Monthly) | 0.448 |
| 52-Week Change | -43.49% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 51.41 USD |
| 52 Week Low | 19.17 USD |
| 50-Day Moving Average | 31.09 USD |
| 200-Day Moving Average | 33.06 USD |
GRRMF Share Statistics
| Avg. Volume (3 month) | 32 USD |
| Avg. Daily Volume (10-Days) | 30 USD |
| Shares Outstanding | 34.54M |
| Float | 32.05M |
| Short Ratio | N/A |
| % Held by Insiders | 11.42% |
| % Held by Institutions | 73.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 47.00% |
| Payout Ratio | 0.0385 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2025 |
| Most Recent Quarter (mrq) | February 28, 2026 |
| Next Fiscal Year End | November 30, 2026 |
Profitability
| Profit Margin | -17.51% |
| Operating Margin (ttm) | -10.96% |
| Gross Margin | 20.95% |
| EBITDA Margin | 13.94% |
Management Effectiveness
| Return on Assets (ttm) | 0.52% |
| Return on Equity (ttm) | -32.35% |
Income Statement
| Revenue (ttm) | 2.32B USD |
| Revenue Per Share (ttm) | 67.09 USD |
| Quarterly Revenue Growth (yoy) | -0.80% |
| Gross Profit (ttm) | 485.57M USD |
| EBITDA | 323.15M USD |
| Net Income Avi to Common (ttm) | -409176000 USD |
| Diluted EPS (ttm) | -10.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 167.61M USD |
| Total Cash Per Share (mrq) | 4.85 USD |
| Total Debt (mrq) | 2.33B USD |
| Total Debt/Equity (mrq) | 236.74 USD |
| Current Ratio (mrq) | 1.069 |
| Book Value Per Share (mrq) | 31.170115 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 261.6M USD |
| Levered Free Cash Flow (ttm) | -175747120 USD |
Profile of Gerresheimer
| Country | United States |
| State | N/A |
| City | Düsseldorf |
| Address | Peter-Müller-Straße 3 |
| ZIP | 40468 |
| Phone | 49 211 61 81 00 |
| Website | https://www.gerresheimer.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 13301 |
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
Q&A For Gerresheimer Stock
What is a current GRRMF stock price?
Gerresheimer GRRMF stock price today per share is 29.05 USD.
How to purchase Gerresheimer stock?
You can buy GRRMF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gerresheimer?
The stock symbol or ticker of Gerresheimer is GRRMF.
Which industry does the Gerresheimer company belong to?
The Gerresheimer industry is Medical Instruments & Supplies.
How many shares does Gerresheimer have in circulation?
The max supply of Gerresheimer shares is 34.54M.
What is Gerresheimer Price to Earnings Ratio (PE Ratio)?
Gerresheimer PE Ratio is now.
What was Gerresheimer earnings per share over the trailing 12 months (TTM)?
Gerresheimer EPS is -10.36 USD over the trailing 12 months.
Which sector does the Gerresheimer company belong to?
The Gerresheimer sector is Healthcare.
